BOULDER, Colo., Nov. 9, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.
Event: |
Stifel 2015 Healthcare Conference |
Date: |
Tuesday, November 17, 2015 |
Time: |
2:15 p.m. Eastern Standard Time |
Location: |
New York Palace Hotel, New York City |
Event: |
Jefferies 2015 Global Healthcare Conference |
Date: |
Thursday, November 19, 2015 |
Time: |
3:20 p.m. Greenwich Mean Time |
Location: |
London, England |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: |
Tricia Haugeto |
Array BioPharma Inc. |
|
303-386-1193 |
|
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
SOURCE Array BioPharma Inc.
Share this article